Methylenetetrahydrofolate reductase polymorphism (MTHFR C677T) and headache in children: A retrospective study from a tertiary level outpatient service

4Citations
Citations of this article
17Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background: In adult studies the MTHFR C677T polymorphism has been associated with an increased risk of migraine, but little research has been done in this area in children. Methods: A retrospective study of children referred with headache to a tertiary level Paediatric Neurology Service between 2008 and 2012. This study included only patients who had been genotyped for the MTHFR C677T polymorphism. An evaluation of homocysteine serum levels was necessary to exclude other types of migraine. Conclusion: Compared with the wild-type genotype, the T/T genotype was associated with an increased risk of any type of migraine, though the statistical significance was greatest in migraine with aura. The homocysteine serum levels were significantly higher in migraine with aura compared to migraine without aura. In a pediatric population MTHFR T/T homozygosity influences susceptibility to migraine.

Cite

CITATION STYLE

APA

Orsini, A., Sammartino, I., Valetto, A., Bertini, V., Marchese, P., Bonuccelli, A., & Peroni, D. G. (2018). Methylenetetrahydrofolate reductase polymorphism (MTHFR C677T) and headache in children: A retrospective study from a tertiary level outpatient service. Italian Journal of Pediatrics, 44(1). https://doi.org/10.1186/s13052-018-0546-1

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free